Your browser doesn't support javascript.
loading
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Sulkowski, Mark S; Moon, Juhi S; Sherman, Kenneth E; Morelli, Giuseppe; Darling, Jama M; Muir, Andrew J; Khalili, Mandana; Fishbein, Dawn A; Hinestrosa, Federico; Shiffman, Mitchell L; Di Bisceglie, Adrian; Rajender Reddy, K; Pearlman, Brian; Lok, Anna S; Fried, Michael W; Stewart, Paul W; Peter, Joy; Wadsworth, Summer; Kixmiller, Scott; Sloan, Anquenette; Vainorius, Monika; Horne, Patrick M; Michael, Larry; Dong, Meichen; Evon, Donna M; Segal, Jodi B; Nelson, David R.
Afiliação
  • Sulkowski MS; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Moon JS; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Sherman KE; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Morelli G; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
  • Darling JM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Muir AJ; Division of Gastroenterology, Duke University, Durham, NC.
  • Khalili M; Department of Medicine, University of California San Francisco, Zuckerberg San Francisco General, Hospital and Trauma Center, San Francisco, CA.
  • Fishbein DA; Infectious Disease, Medstar Health Research Institute, Washington, DC.
  • Hinestrosa F; Infectious Disease, Orlando Immunology Center, Orlando, FL.
  • Shiffman ML; Department of Gastroenterology, Liver Institute of Virginia, Richmond, VA.
  • Di Bisceglie A; Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO.
  • Rajender Reddy K; Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Pearlman B; Department of Internal Medicine, Wellstar Health System, Atlanta, GA.
  • Lok AS; Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
  • Fried MW; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Stewart PW; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Peter J; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
  • Wadsworth S; PRIORITIZE Patient Engagement Group consultant, Garner, NC.
  • Kixmiller S; PRIORITIZE Patient Engagement Group consultant, Greensboro, NC.
  • Sloan A; PRIORITIZE Patient Engagement Group consultant, Pittsboro, NC.
  • Vainorius M; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Horne PM; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
  • Michael L; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Dong M; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Evon DM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Segal JB; Division of Internal Medicne, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Nelson DR; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
Hepatology ; 74(6): 2952-2964, 2021 12.
Article em En | MEDLINE | ID: mdl-34255381
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepacivirus / Hepatite C Crônica Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Hepatology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Moldávia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepacivirus / Hepatite C Crônica Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Hepatology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Moldávia